ALKS — Alkermes plc. catalysts
Next verified catalyst
2026-09-01 — Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects W · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric
Phase 3 · Schizophrenia, Bipolar I Disorder |
ALKS Alkermes plc. | OLZ/SAM, Olanzapine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|